4th Quarter - Report

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
$2,021,850
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Pharmaceutical intellectual property issues

LobbyistCovered position, as disclosed
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO New Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Puerto Rico tax issues; "Inflation Reduction Act" (HR.5376); expensing of research and development costs

LobbyistCovered position, as disclosed
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO New Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Pharmacy PHA

Hospital discounts; 340B program; Affordable Prescriptions for Patients Act of 2021 (S.1435)

LobbyistCovered position, as disclosed
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO New Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1435 (117th)

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
HEATHER CLARK —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO —
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)
DAVID TALBOT —

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Patient protection; Drug supply chain and shortages; Drug pricing, coverage, value and access; Transparency; Intellectual property; Health insurance accessibility; "Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act 2021" (S 2076 & HR.3932); "Inflation Reduction Act" (HR.5376); Affordable Prescriptions for Patients Act of 2021 (S.1435); Prescription Drug User Fee reauthorization; prescription drug approval; Affordable Insulin Now Act (S.3700/HR.6833), The INSULIN Act

LobbyistCovered position, as disclosed
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO New Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), S. 1435 (117th), H.R. 6833 (117th), S. 3700 (117th), H.R. 3932 (117th)

Medicare/Medicaid MMM

Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement, coverage and value; "Developing an Innovative Strategy for Antimicrobial Resistant Microorganism Act of 2019 (DISARM Act)"; "Inflation Reduction Act" (HR.5376); Affordable Prescriptions for Patients Act of 2021 (S.1435); CMS National Coverage Determination on Alzheimer's disease; The INSULIN Act

LobbyistCovered position, as disclosed
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO New Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 5376 (117th), S. 1435 (117th)

Consumer Issues/Safety/Products CSP

Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access; "Affordable Prescriptions for Patients Act of 2021 (S 1435 & HR.2873); Affordable Prescriptions for Patients Act of 2021 (S.1435)

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
HEATHER CLARK —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO New Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA New Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)
DAVID TALBOT —

Contacted: U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Executive Office of the President (EOP); Office of Management & Budget (OMB)

Bills named: S. 1435 (117th), H.R. 2873 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.